Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 213

1.

Differentiation therapy for acute promyelocytic leukemia with all-trans retinoic acid: 10-year experience of its clinical application.

Wang Z, Sun G, Shen Z, Chen S, Chen Z.

Chin Med J (Engl). 1999 Nov;112(11):963-7. Review.

PMID:
11721474
2.

[Arsenic trioxide in combination with all-trans retinoic acid for acute promyelocytic leukemia: a systematic review and meta-analysis].

Xu SN, Chen JP, Liu JP, Xia Y.

Zhong Xi Yi Jie He Xue Bao. 2009 Nov;7(11):1024-34. doi: 10.3736/jcim20091102. Review. Chinese.

3.

Long-term survey of outcome in acute promyelocytic leukemia.

Hu J, Shen Z, Sun H, Wu W, Li X, Sun G, Wang Z.

Chin Med J (Engl). 2000 Feb;113(2):107-10.

PMID:
11775530
4.

All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia.

Fenaux P, Chomienne C, Degos L.

Semin Hematol. 2001 Jan;38(1):13-25. Review.

PMID:
11172536
5.

Acute promyelocytic leukemia.

Douer D.

Curr Treat Options Oncol. 2000 Apr;1(1):31-40. Review.

PMID:
12057059
6.

All trans retinoic acid in acute promyelocytic leukemia.

Degos L, Wang ZY.

Oncogene. 2001 Oct 29;20(49):7140-5. Review.

7.

[Treatment of acute promyelocytic leukemia by all trans retinoic acid].

Castaigne S, Degos L.

C R Seances Soc Biol Fil. 1995;189(4):515-20. French.

PMID:
8564565
8.

Use of all-trans retinoic acid in combination with arsenic trioxide for remission induction in patients with newly diagnosed acute promyelocytic leukemia and for consolidation/maintenance in CR patients.

Dai CW, Zhang GS, Shen JK, Zheng WL, Pei MF, Xu YX, Cao YX, Yi Y, Yang JJ, Peng HL, Zhong HY, Li RJ.

Acta Haematol. 2009;121(1):1-8. doi: 10.1159/000204472. Epub 2009 Feb 26. Erratum in: Acta Haematol. 2009;121(4):243.

PMID:
19246888
9.
10.

All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia.

Shen ZX, Shi ZZ, Fang J, Gu BW, Li JM, Zhu YM, Shi JY, Zheng PZ, Yan H, Liu YF, Chen Y, Shen Y, Wu W, Tang W, Waxman S, De Thé H, Wang ZY, Chen SJ, Chen Z.

Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5328-35. Epub 2004 Mar 24.

11.

Acute promyelocytic leukemia: evolving therapeutic strategies.

Tallman MS, Nabhan C, Feusner JH, Rowe JM.

Blood. 2002 Feb 1;99(3):759-67. Review.

12.

Combined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemia.

Raffoux E, Rousselot P, Poupon J, Daniel MT, Cassinat B, Delarue R, Taksin AL, Réa D, Buzyn A, Tibi A, Lebbé G, Cimerman P, Chomienne C, Fermand JP, de Thé H, Degos L, Hermine O, Dombret H.

J Clin Oncol. 2003 Jun 15;21(12):2326-34.

PMID:
12805334
13.

[Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].

Rolovitsh Z, Cholovitsh M, Elezovitsh I, Vidovitsh A, Radoshevitsh-Radojkovitsh N, Boshkovitsh D, Novak A, Basara N.

Srp Arh Celok Lek. 1995 Nov-Dec;123(11-12):279-85. Serbian.

PMID:
16296239
14.

All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemia.

Quezada G, Kopp L, Estey E, Wells RJ.

Pediatr Blood Cancer. 2008 Jul;51(1):133-5. doi: 10.1002/pbc.21529.

PMID:
18293388
15.
16.

[Induction therapy of acute promyelocytic leukemia with all-trans retinoic acid: a case, followed by conventional post-remission chemotherapy in complete remission].

Tsukada T, Mahmud N, Taniguchi M, Takahashi T, Kihira H, Kita K, Kobayashi T, Deguchi K, Shirakawa S.

Rinsho Ketsueki. 1992 Dec;33(12):1880-3. Japanese.

PMID:
1479702
17.

Administration of granulocyte colony-stimulating factor during remission induction therapy with all-trans retinoic acid for acute promyelocytic leukemia.

Usuki K, Nishizawa Y, Endo M, Osawa M, Kitazume K, Iki S, Watanabe M, Urabe A.

Int J Hematol. 1996 Oct;64(3-4):213-9.

PMID:
8923783
18.

Use of trans-retinoic acid in the treatment of acute promyelocytic leukemia.

Dulaney AM, Murgatroyd RJ.

Ann Pharmacother. 1993 Feb;27(2):211-4. Review.

PMID:
8439701
19.

Advances in the treatment of relapsed acute promyelocytic leukemia.

Douer D.

Acta Haematol. 2002;107(1):1-17. Review.

PMID:
11818666
20.

Role of all-trans-retinoic acid (ATRA) in the consolidation therapy of acute promyelocytic leukaemia (APL).

Gupta V, Yi QL, Brandwein J, Lipton JH, Messner HA, Schuh AC, Wells RA, Minden MD.

Leuk Res. 2005 Jan;29(1):113-4.

PMID:
15541484

Supplemental Content

Support Center